Bioqual Inc (BIOQ)
72.50
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Bioqual Price to Book Value: 1.684 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.684 |
| May 15, 2024 | 1.684 |
| May 14, 2024 | 1.684 |
| May 13, 2024 | 1.684 |
| May 10, 2024 | 1.684 |
| May 09, 2024 | 1.684 |
| May 08, 2024 | 1.684 |
| May 07, 2024 | 1.684 |
| May 06, 2024 | 1.684 |
| May 03, 2024 | 1.684 |
| May 02, 2024 | 1.684 |
| May 01, 2024 | 1.684 |
| April 30, 2024 | 1.684 |
| April 29, 2024 | 1.742 |
| April 26, 2024 | 1.742 |
| April 25, 2024 | 1.742 |
| April 24, 2024 | 1.742 |
| April 23, 2024 | 1.742 |
| April 22, 2024 | 1.742 |
| April 19, 2024 | 1.742 |
| April 18, 2024 | 1.742 |
| April 17, 2024 | 1.742 |
| April 16, 2024 | 1.742 |
| April 15, 2024 | 1.742 |
| April 12, 2024 | 1.742 |
| Date | Value |
|---|---|
| April 11, 2024 | 1.742 |
| April 10, 2024 | 1.742 |
| April 09, 2024 | 1.742 |
| April 08, 2024 | 1.858 |
| April 05, 2024 | 1.858 |
| April 04, 2024 | 1.858 |
| April 03, 2024 | 1.858 |
| April 02, 2024 | 1.858 |
| April 01, 2024 | 1.858 |
| March 28, 2024 | 1.858 |
| March 27, 2024 | 1.858 |
| March 26, 2024 | 1.858 |
| March 25, 2024 | 1.858 |
| March 22, 2024 | 1.858 |
| March 21, 2024 | 1.858 |
| March 20, 2024 | 1.858 |
| March 19, 2024 | 1.858 |
| March 18, 2024 | 1.858 |
| March 15, 2024 | 1.858 |
| March 14, 2024 | 1.858 |
| March 13, 2024 | 1.858 |
| March 12, 2024 | 1.858 |
| March 11, 2024 | 1.748 |
| March 08, 2024 | 1.748 |
| March 07, 2024 | 1.748 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.0016
Minimum
Aug 22 2019
1.858
Maximum
Mar 12 2024
0.2274
Average
0.0048
Median
Aug 07 2020
Price to Book Value Benchmarks
| CEL-SCI Corp | 5.547 |
| AIM ImmunoTech Inc | 2.138 |
| IGC Pharma Inc | 3.957 |
| NovaBay Pharmaceuticals Inc | -- |
| Protalix BioTherapeutics Inc | 2.818 |
Price to Book Value Related Metrics
| Price | 72.50 |
| Market Cap | 64.84M |